Drug price history · CMS NADAC read 11 November 2026
Generic Over the counter
$0.097 per unit at the 2013 year-end survey (3 NDCs) and $0.094 at the 2026 survey (8 NDCs): −3%.
| Year-end survey | Median per unit | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.097 | 3 | |
| 2014 (2014-12-31) | $0.101 | 3 | |
| 2015 (2015-12-30) | $0.126 | 4 | |
| 2016 (2016-12-28) | $0.128 | 3 | |
| 2017 (2017-12-27) | $0.118 | 3 | |
| 2018 (2018-12-26) | $0.115 | 3 | |
| 2019 (2019-12-25) | $0.117 | 3 | |
| 2020 (2020-12-30) | $0.106 | 3 | |
| 2021 (2021-12-29) | $0.104 | 5 | |
| 2022 (2022-12-28) | $0.106 | 9 | |
| 2023 (2023-12-27) | $0.103 | 8 | |
| 2024 (2024-12-25) | $0.097 | 8 | |
| 2025 (2025-12-31) | $0.099 | 8 | |
| 2026 (2026-11-11) | $0.094 | 8 |
Generic
$0.036 per unit at the 2013 year-end survey (25 NDCs) and $0.028 at the 2026 survey (49 NDCs): −22%.
| Year-end survey | Median per unit | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.036 | 25 | |
| 2014 (2014-12-31) | $0.047 | 27 | |
| 2015 (2015-12-30) | $0.043 | 22 | |
| 2016 (2016-12-28) | $0.041 | 19 | |
| 2017 (2017-12-27) | $0.036 | 20 | |
| 2018 (2018-12-26) | $0.033 | 19 | |
| 2019 (2019-12-25) | $0.035 | 22 | |
| 2020 (2020-12-30) | $0.060 | $0.060 to $0.150 | 19 |
| 2021 (2021-12-29) | $0.034 | $0.034 to $0.152 | 26 |
| 2022 (2022-12-28) | $0.031 | $0.031 to $0.144 | 34 |
| 2023 (2023-12-27) | $0.033 | $0.033 to $0.140 | 38 |
| 2024 (2024-12-25) | $0.029 | $0.029 to $0.142 | 45 |
| 2025 (2025-12-31) | $0.029 | $0.029 to $0.147 | 52 |
| 2026 (2026-11-11) | $0.028 | $0.028 to $0.138 | 49 |
Generic
$0.073 per unit at the 2013 year-end survey (15 NDCs) and $0.048 at the 2026 survey (33 NDCs): −35%.
| Year-end survey | Median per unit | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.073 | 15 | |
| 2014 (2014-12-31) | $0.066 | 18 | |
| 2015 (2015-12-30) | $0.073 | 14 | |
| 2016 (2016-12-28) | $0.081 | 14 | |
| 2017 (2017-12-27) | $0.075 | 17 | |
| 2018 (2018-12-26) | $0.072 | 16 | |
| 2019 (2019-12-25) | $0.065 | 17 | |
| 2020 (2020-12-30) | $0.091 | 15 | |
| 2021 (2021-12-29) | $0.070 | 16 | |
| 2022 (2022-12-28) | $0.059 | 22 | |
| 2023 (2023-12-27) | $0.062 | 24 | |
| 2024 (2024-12-25) | $0.052 | 32 | |
| 2025 (2025-12-31) | $0.052 | 34 | |
| 2026 (2026-11-11) | $0.048 | 33 |
Generic
$1.02 per mL at the 2013 year-end survey (4 NDCs) and $0.127 at the 2026 survey (17 NDCs): −88%.
| Year-end survey | Median per mL | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $1.02 | 4 | |
| 2014 (2014-12-31) | $0.987 | 4 | |
| 2015 (2015-12-30) | $1.03 | 4 | |
| 2016 (2016-12-28) | $0.852 | 3 | |
| 2017 (2017-12-27) | $0.873 | 2 | |
| 2018 (2018-12-26) | $0.797 | 2 | |
| 2019 (2019-12-25) | $0.837 | 1 | |
| 2020 (2020-12-30) | $1.29 | 1 | |
| 2021 (2021-12-29) | $0.949 | 4 | |
| 2022 (2022-12-28) | $0.637 | 5 | |
| 2023 (2023-12-27) | $0.562 | 9 | |
| 2024 (2024-12-25) | $0.313 | $0.280 to $0.497 | 13 |
| 2025 (2025-12-31) | $0.214 | $0.214 to $0.492 | 16 |
| 2026 (2026-11-11) | $0.127 | $0.067 to $0.494 | 17 |
Generic
Priced once, at the 2026 year-end survey: $0.303 per mL across 5 NDCs.
| Year-end survey | Median per mL | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2026 (2026-11-11) | $0.303 | 5 |
CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.
The FDA Orange Book lists 22 generic makers as marketed in its largest dosage form for Famotidine, and the first generic approval is dated 16 April 2001. The acquisition costs above are what pharmacies pay across the NDCs priced; the Orange Book count is a separate record and this page does not say that more makers lowered a price. See each maker and the patents still listed on OmniRx.
Open it in the check to search another drug, or see the CMS pharmacy pricing page for what NADAC measures. For who makes the generic and which patents are listed, see the generic competition check for Famotidine on OmniRx. To check whether a drug is in shortage, see the FDA drug shortages page.
Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the CMS pharmacy pricing page, year-end surveys 2013 to 2026 (latest 11 November 2026).